Investment House LLC lowered its stake in shares of CVS Health Co. (NYSE:CVS) by 14.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 21,312 shares of the pharmacy operator’s stock after selling 3,606 shares during the quarter. Investment House LLC’s holdings in CVS Health were worth $1,456,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. United Bank grew its position in CVS Health by 25.1% in the 2nd quarter. United Bank now owns 11,731 shares of the pharmacy operator’s stock valued at $762,000 after acquiring an additional 2,353 shares during the last quarter. PNC Financial Services Group Inc. grew its position in CVS Health by 2.6% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,124,772 shares of the pharmacy operator’s stock valued at $138,049,000 after acquiring an additional 53,819 shares during the last quarter. Advisors Capital Management LLC grew its position in CVS Health by 8.7% in the 2nd quarter. Advisors Capital Management LLC now owns 5,203 shares of the pharmacy operator’s stock valued at $338,000 after acquiring an additional 418 shares during the last quarter. Orion Portfolio Solutions LLC grew its position in CVS Health by 47.4% in the 2nd quarter. Orion Portfolio Solutions LLC now owns 5,042 shares of the pharmacy operator’s stock valued at $328,000 after acquiring an additional 1,621 shares during the last quarter. Finally, RMR Wealth Builders bought a new position in CVS Health in the 2nd quarter valued at $88,000. 74.21% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE CVS traded down $1.34 during mid-day trading on Wednesday, reaching $74.92. 6,170,662 shares of the company were exchanged, compared to its average volume of 8,403,607. The company has a quick ratio of 0.67, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. The stock has a market cap of $98.06 billion, a price-to-earnings ratio of 12.38, a P/E/G ratio of 1.69 and a beta of 0.82. CVS Health Co. has a 1 year low of $52.04 and a 1 year high of $77.23. The firm has a 50-day moving average of $70.40 and a 200 day moving average of $64.26.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 11th. The pharmacy operator reported $1.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.33 by $0.33. CVS Health had a return on equity of 15.60% and a net margin of 2.99%. The company had revenue of $67.05 billion for the quarter, compared to analyst estimates of $66.54 billion. During the same period in the prior year, the company posted $1.84 EPS. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Co. will post 7.43 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 1st. Investors of record on Friday, January 22nd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend is Thursday, January 21st. CVS Health’s dividend payout ratio is currently 28.25%.

Several equities analysts have commented on the company. Deutsche Bank Aktiengesellschaft cut their price objective on CVS Health from $104.00 to $101.00 and set a “buy” rating on the stock in a research report on Monday, November 9th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Monday, November 9th. SVB Leerink upped their target price on CVS Health from $73.00 to $80.00 and gave the stock a “market perform” rating in a report on Monday, December 14th. Jefferies Financial Group upgraded CVS Health from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a report on Friday, January 8th. Finally, Piper Sandler upped their target price on CVS Health from $72.00 to $76.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. CVS Health currently has a consensus rating of “Buy” and a consensus target price of $82.93.

In other news, EVP Lisa Bisaccia sold 25,177 shares of the stock in a transaction dated Tuesday, January 12th. The stock was sold at an average price of $77.00, for a total value of $1,938,629.00. Following the transaction, the executive vice president now directly owns 71,765 shares of the company’s stock, valued at $5,525,905. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Alan Lotvin sold 7,138 shares of the stock in a transaction dated Friday, November 13th. The shares were sold at an average price of $70.00, for a total value of $499,660.00. Following the completion of the transaction, the executive vice president now directly owns 8,023 shares in the company, valued at $561,610. The disclosure for this sale can be found here. Insiders have sold a total of 58,151 shares of company stock worth $4,375,989 over the last ninety days. 0.46% of the stock is currently owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

Featured Story: What does a bar chart display?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.